Log In
BCIQ
Print this Print this
 

Topical INCB18424

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionTopical janus kinase-1 (JAK-1) and janus kinase-2 (JAK-2) inhibitor
Molecular Target Janus kinase-1 (JAK-1) ; Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today